Hong Kong – 18 November 2026 – MINISO Group Holding Limited (MNSO) has issued 11.66 million new restricted share units (RSUs) to 252 employees and converted a further 0.75 million unvested 2025-dated RSUs to be settled in new shares, according to a stock exchange filing. The combined 12.41 million RSUs equate to 1.02 percent of MINISO’s outstanding share capital and will be sourced entirely from new share issuance under the company’s 2020 Share Incentive Plan.
Key details of the latest equity awards • New RSU grant: 11.66 million units (0.96 percent of shares outstanding), priced at US$0.00001 per unit, based on a HK$23.50 closing price on the grant date. • 2025 RSU variation: 0.75 million units (0.06 percent), originally due to be settled with existing shares, will now be settled with new shares. • Vesting: Awards vest over four months to five years, starting March 2027, with tranches ranging from 0.1 percent to 35.5 percent of the grant on specified dates through December 2031. • Performance conditions: 11.09 million RSUs (involving 242 grantees) depend on group financial metrics and departmental KPIs; remaining RSUs carry no performance hurdles. • Clawback: Unvested awards lapse if employment ends for specified reasons; vested shares may be reclaimed for misconduct or competitive activity. • Beneficiaries: All grantees are employees below director or senior-management level; no individual exceeds the 1 percent cap on annual awards.
Revisions to earlier grants The board also revised vesting terms for 12.81 million unvested RSUs granted in March 2024 and 0.21 million unvested RSUs granted in April 2026. Vesting is now staggered annually from March 2027 to March 2031, with early-vesting provisions should the group meet overarching performance targets in any year from 2026 to 2030.
Plan capacity Following the new grants, 22.29 million shares remain available for future awards under the 2020 Share Incentive Plan, of which 19.39 million can be issued within the existing scheme mandate. The Hong Kong Stock Exchange previously approved listing of shares issuable under the plan on 12 July 2022.
Strategic rationale Management states the refreshed grants and revised vesting schedules aim to retain key talent, align employee interests with shareholder value and support strategic objectives through 2030. No shareholder approval is required for the transactions under prevailing plan limits and Listing Rules.
Comments